# Magnetic Seizure Therapy Versus Electroconvulsive Therapy for Schizophrenia

> **NCT03007628** · NA · COMPLETED · sponsor: **Shanghai Mental Health Center** · enrollment: 40 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DEVICE:** Magpro X100
- **DEVICE:** ThymatronSystem Ⅳ Electroconvulsive System
- **OTHER:** Treatment as usual (TAU)

## Key facts

- **NCT ID:** NCT03007628
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2019-07
- **Final completion:** 2019-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03007628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03007628, "Magnetic Seizure Therapy Versus Electroconvulsive Therapy for Schizophrenia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03007628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*